Athanassios Alevizopoulos
Chief Executive Officer at TheraPten Biosciences, Inc.
Profile
Athanassios Alevizopoulos is the founder of TheraPten Biosciences, Inc. He currently holds the title of Chairman & Chief Executive Officer at the company, which was founded in 2016.
Athanassios Alevizopoulos active positions
| Companies | Position | Start |
|---|---|---|
TheraPten Biosciences, Inc.
 TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada. | Chief Executive Officer | 22/02/2016 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
TheraPten Biosciences, Inc.
TheraPten Biosciences, Inc. BiotechnologyHealth Technology TheraPten Biosciences, Inc. develops anti-cancer protein therapeutics. Its PTEN-L, is a natural human anti-cancer tumor suppressor protein, as an injectable biological therapy. The company was founded by Athanassios Alevizopoulos , Harvey Lalach and Ramon Parsons and is headquartered in Kelowna, Canada. | Health Technology |
- Stock Market
- Insiders
- Athanassios Alevizopoulos
